Fagron NV signed an agreement to acquire Parma Produkt Gyógyszergyártó Korlátolt Felelosségu Társaság.
close early January 2024.
Market Closed -
Other stock markets
|
After market 02:12:30 pm | |||
18.76 EUR | +0.97% | 18.77 | +0.05% |
Apr. 11 | Transcript : Fagron NV, Q1 2024 Sales/ Trading Statement Call, Apr 11, 2024 | |
Apr. 11 | Fagron Reports Revenue Results for the First Quarter Ended 31 March 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+12.94% | 1.5B | |
+38.20% | 705B | |
+32.82% | 583B | |
-3.77% | 364B | |
+19.90% | 332B | |
+4.94% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+8.73% | 169B |